Projects

Mgr. Petra Petrovičová

International

Finished
  • Individual radiosensitivity of cancer patients and nuclear-chemical personnel
    Program: Inter-academic agreement
    Duration: 1. 1. 2013 – 31. 12. 2015

National

Current
  • Individual radiosensitivity of cancer patients and use of Gingko biloba in the prevention of radiotherapy induced side effects
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • Study of genotoxic  effects from magnetic resonance imaging in human lymphocytes
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • Radiation-induced noncoding RNAs in mononuclear cells of umbilical cord blood
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
  • Study of genetic instability in cells from leukemic patients and chemotherapy-resistant preleukemic stem cells at remission for prevention of relapses 
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
Finished
  • Mechanisms of impact of low intensity electromagnetic radiation on course of cancer disease
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Biomarkers for assessment of individual radiosensitivity in breast cancer therapy
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • Constitutive and induced DNA damage in hematopoietic cells for assessment of risk and optimizing treatment of childhood leukemia
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Preleukemic gene fusions and DNA repair in umbilical cord blood cells
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Molecular markers of DNA repair in cancer therapy
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2014
  • Implementation of radiobiological research of intensity-modulated proton therapy into clinical oncology practice
    Program: EU Structural Funds Research & Development
    Duration: 20. 10. 2010 – 31. 3. 2014
Employees